{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:24:11Z","timestamp":1776983051161,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gastric cancer, characterized by insidious onset and multiple metastasis, is almost incurable and has poor prognosis, and also one of the leading causes of treatment failure and death in patients with gastric cancer (GC). However, the prognosis of collagen type V alpha2 chain (COL5A2) in GC and renal metastasis is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Recruited 148 patients who underwent GC. The diagnosis of GC was confirmed by ultrasound imaging and pathological examination. Immunohistochemistry and RT-qPCR were performed to exam the expression level of COL5A2. The statistical methods included Pearson chi-square test, Spearman-rho correlation test, univariate and multivariate cox regression analysis. Finally, this research constructed receiver operating characteristic (ROC) curves and applied the area under the curve (AUC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Based on Pearson's chi-square test, Spearman-rho test, and univariate\/multivariate cox regression, pathologic grade (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), renal metastasis (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and staging (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) were significantly related to COL5A2. And COL5A2 expression (hazard ratio [HR]: 18.834, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) is an independent risk factor of GC. The AUC was used as the degree of confidence in judging each factor: COL5A2 (AUC\u200a=\u200a0.878, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), COL1A1 (AUC\u200a=\u200a0.636, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.006), COL1A2 (AUC\u200a=\u200a0.545, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.368), and COL3A1 (AUC\u200a=\u200a0.617, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.019). Through the ROC result, COL5A2 had more advantage as a biomarker for GC than other collagens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>COL5A2 gene expression level might be a risk factor for GC. COL5A2 has a strong correlation with the prognosis of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024561","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T21:22:40Z","timestamp":1614374560000},"page":"e24561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis"],"prefix":"10.1097","volume":"100","author":[{"given":"Yun-Long","family":"Ding","sequence":"first","affiliation":[{"name":"Emergency Department, Weifang People's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Fang","family":"Sun","sequence":"additional","affiliation":[{"name":"Anaesthesiology Department, Weifang Maternal and Child Health Care Hospital, Weifang, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-9383","authenticated-orcid":false,"given":"Guang-Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Emergency Department, Weifang People's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13304-018-0543-3","article-title":"Progress in gastric cancer","volume":"70","author":"Strong","year":"2018","journal-title":"Updates Surg"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11894-016-0506-0","article-title":"Gastric cancer: how can we reduce the incidence of this disease","volume":"18","author":"den Hoed","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4166\/kjg.2017.69.5.270","article-title":"Micrometastasis in gastric cancer","volume":"69","author":"Youn","year":"2017","journal-title":"Korean J Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10555-019-09803-7","article-title":"Update on gastric cancer treatments and gene therapies","volume":"38","author":"Biagioni","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3748\/wjg.v25.i17.2029","article-title":"Recent advances in gastric cancer early diagnosis","volume":"25","author":"Necula","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1245\/s10434-017-5882-7","article-title":"FBXO50 enhances the malignant behavior of gastric cancer cells","volume":"24","author":"Miwa","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/carcin\/22.6.875","article-title":"Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2","volume":"22","author":"Fischer","year":"2001","journal-title":"Carcinogenesis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/tbj.13684","article-title":"Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis","volume":"26","author":"Srour","year":"2020","journal-title":"Breast J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.7150\/jca.26382","article-title":"NKX2-2 suppresses osteosarcoma metastasis and proliferation by downregulating multiple target genes","volume":"9","author":"Chen","year":"2018","journal-title":"J Cancer"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e0091","DOI":"10.1097\/MD.0000000000010091","article-title":"The clinical significance of COL5A2 in patients with bladder cancer: a retrospective analysis of bladder cancer gene expression data","volume":"97","author":"Zeng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ajpath.2017.06.006","article-title":"Deficits in Col5a2 expression result in novel skin and adipose abnormalities and predisposition to aortic aneurysms and dissections","volume":"187","author":"Park","year":"2017","journal-title":"Am J Pathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.ajpath.2015.03.022","article-title":"Homozygosity and heterozygosity for null Col5a2 alleles produce embryonic lethality and a novel classic Ehlers-Danlos syndrome-related phenotype","volume":"185","author":"Park","year":"2015","journal-title":"Am J Pathol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e5180","DOI":"10.7717\/peerj.5180","article-title":"Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis","volume":"6","author":"Cao","year":"2018","journal-title":"PeerJ"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/ijms19103028","article-title":"Role of extracellular matrix in development and cancer progression","volume":"19","author":"Walker","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7827-2-2","article-title":"Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer","volume":"2","author":"Stewart","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin Exp Metastasis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","article-title":"The extracellular matrix modulates the metastatic journey","volume":"49","author":"Kai","year":"2019","journal-title":"Dev Cell"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13205-019-1616-9","article-title":"Comparative genomic analysis of collagen gene diversity","volume":"9","author":"Haq","year":"2019","journal-title":"3 Biotech"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"St","year":"2000","journal-title":"Science"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/cells8091054","article-title":"Identification of transcriptional markers and microRNA-mRNA regulatory networks in colon cancer by integrative analysis of mRNA and microRNA expression profiles in colon tumor stroma","volume":"8","author":"Uddin","year":"2019","journal-title":"Cells"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12253-017-0223-5","article-title":"COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: integrating bioinformatics and meta-analysis","volume":"24","author":"Rong","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/jcb.26524","article-title":"Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway","volume":"119","author":"Ao","year":"2018","journal-title":"J Cell Biochem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12957-016-1056-5","article-title":"Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer","volume":"14","author":"Li","year":"2016","journal-title":"World J Surg Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1159\/000453184","article-title":"Elevated THBS2, COL1A2, and SPP1 expression levels as predictors of gastric cancer prognosis","volume":"40","author":"Zhuo","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fgene.2018.00265","article-title":"Identification of potential key genes associated with the pathogenesis and prognosis of gastric cancer based on integrated bioinformatics analysis","volume":"9","author":"Liu","year":"2018","journal-title":"Front Genet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1476-4598-13-225","article-title":"Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer","volume":"13","author":"Sun","year":"2014","journal-title":"Mol Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:15:45Z","timestamp":1746339345000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024561","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"2020-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}